Medical Device News Magazine:

What are the future trends of medical devices?  In the rapidly evolving landscape of healthcare, staying informed about the latest advancements in medical technology is essential for professionals and enthusiasts alike. This publication serves as a vital resource, offering insights into cutting-edge innovations, regulatory developments, FDA medical device news, and other industry trends that impact both patient care and business strategies. We aim to bridge the gap between healthcare professionals, investors, and the medical device industry, providing a comprehensive platform of medical device news that can result in discussions on medical device/biotechnology advancements and their implications for the future of medicine. Read this medtech magazine as we explore the intersection of technology and healthcare, facilitating informed decision-making and fostering collaboration within this dynamic field. Inquire about advertising. Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

Featured Byline

Putting an End to Infusion Confusion with Smart, Simple Solutions | By Rodney W Schutt

Mr. Schutt writes: "Nurses, clinicians, and caregivers across the globe are busier and under more stress than ever before. Every day, they are expected to provide increasingly high-quality care while their resource levels remain woefully inadequate. When managing a high volume of patients, nurses face constant physical and mental strain that can quickly lead to burnout, in a space where even minor clinical errors can be harmful, even fatal."

Views from our Experts

Executives on the Move

Medtronic Appoints Thierry Piéton as Chief Financial Officer

Thierry Piéton will be responsible for leading the Medtronic global finance organization and key supporting functions, including Treasury, Controller, Tax, Internal Audit, Investor Relations, Corporate Strategy, and Business Development.

WorldQuant Foundry Appoints Dr Christopher Mason as Senior Healthcare Advisor to Spearhead AI-Driven Healthcare Innovation

In his new role, Dr. Mason will collaborate with the WorldQuant Foundry ecosystem of entrepreneurs and data scientists in an effort to identify and develop transformative opportunities in the healthcare sector.

Featured News

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

Glox Therapeutics will receive up to £500,000 of the fund to accelerate the development of its novel precision antibiotics, helping to address the growing need for effective treatments to overcome antimicrobial-resistant lung infections in people with cystic fibrosis.

Funding / Acquistions / Mergers

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

Glox Therapeutics will receive up to £500,000 of the fund to accelerate the development of its novel precision antibiotics, helping to address the growing need for effective treatments to overcome antimicrobial-resistant lung infections in people with cystic fibrosis.

Clinical Trials

Neogap Therapeutics Reports First Patients Treated in Neogap Personalized Immunotherapy Trial

“We are delighted to have treated the first patients – this is a significant milestone in our clinical trial and our mission to develop curative treatments for critically ill cancer patients. We have an outstanding trial team and look forward to the upcoming results,” says Samuel Svensson, CEO of Neogap Therapeutics.

Biotechnology

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

"Our AI-powered pipeline represents a major leap forward for IPA," said Dr. Jennifer Bath, CEO of ImmunoPrecise Antibodies. "By harnessing AI and rethinking drug discovery from the ground up, we are not just improving the process—we are fundamentally changing what’s possible. This pipeline lays the foundation for groundbreaking advancements in therapeutic development, embodying our vision of innovation driven by clarity, precision, and purpose."

Revvity and Element Biosciences Collaboration | To Advance Sequencing-based IVD Neonatal Testing

"This strategic endeavor represents a significant step forward in our commitment to advancing newborn health through innovative genomic technologies," said Yves Dubaquie, senior vice president, diagnostics at Revvity. "By combining our expertise in newborn screening and rare disease detection with Element’s technological capabilities, Revvity aims to deliver a robust, efficient, and accessible solution for neonatal sequencing in both research and clinical settings."
Spot_Img

More News

Hospitals In the News

FDA

Non-Profit News

Non-Profit News

Healthcare / Business / Careers

Healthcare Professionals

The Business of Healthcare

Careers

Nurses

Spot_Img
Spot_Img
Spot_Img